Recent federal research security initiatives have put the U.S. at risk of losing its lead in science and technology, write senior fellow Neal F. Lane, Steven Pei, and Jeremy Wu. They lay out a path toward clear, fair policy that safeguards America’s security and competitiveness while fostering a welcoming research environment for foreign talent.
In the fight against Mexican criminal cartels, social network analysis can predict and map out their alliances and subgroups — using algorithms to predict new connections. In this commentary, Nonresident Scholar in Drug Policy and Mexico Studies Nathan P. Jones and his co-authors outline their recent work in the field.
Nathan P. Jones, Oscar Contreras Velasco, John P. Sullivan, Chris Callaghan, Irina Chindea, Daniel Weisz ArgomedoOctober 18, 2023
As false or inaccurate information about stem cell interventions continues to circulate widely, the authors write that immediate action is needed to improve patient education and safety — and to combat misinformation more broadly.
Nonresident scholar Nathan P. Jones analyzes Joaquin "El Chapo" Guzman’s transfer to a Mexican prison near the Texas border and how it may impact his possible extradition and prosecution in the U.S.
Baker Institute experts explain how Friday's arrest of Mexican drug lord Joaquin "El Chapo" Guzman will affect the Peña Nieto administration, the Sinaloa Cartel and the Mexican government's "kingpin strategy" to destroy the cartels.
Tony Payan, Gary J. Hale, Nathan P. JonesJanuary 9, 2016
How will Mexico's government and military respond in the long run to the humiliating escape of Chapo Guzman, the country's most powerful drug trafficker?
Genomic testing is a rapidly growing field, especially in cancer medicine, where it can be used to match patients to the most effective targeted treatment. In the past decade, we have seen rapid growth in the number of new genomic tests that are available. However, genomic testing is usually very expensive, raising the question of whether the testing is worth the cost.
